Immucell (ICCC) Selling, General & Administrative (2010 - 2026)
Immucell (ICCC) recorded Selling, General & Administrative of $1.27 million in Q2 2026, up 76.6% from $720,418 a year earlier.
Powered by 
Analysis
Immucell (ICCC) Selling, General & Administrative (2010 - 2026) Analysis & Trends
On a TTM basis, Immucell's Selling, General & Administrative came in at $3.85 million as of Jun 30, 2026, up 58.7% year-over-year; for FY2025, it was $3.2 million, up 44.4% from FY2024.
- Annual Selling, General & Administrative has a five-year compound annual growth rate of 13.2% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $2.22 million in FY2024 (+3.9%), $2.13 million in FY2023 (-5.7%), $2.26 million in FY2022 (+31.2%) and $1.73 million in FY2021 (+0.3%).
- The Q2 2026 figure is the highest quarterly Selling, General & Administrative in data going back to Q2 2010.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 103.3% in Q4 2025, against a decline of 17.2% in Q1 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Immucell | 94.00 Mn | 71.45 Mn | 2.44 Mn | 1.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 729,421.00 |
| Jun 30, 2025 | 720,418.00 |
| Mar 31, 2025 | 622,843.00 |
| Dec 31, 2024 | 554,711.00 |
| Sep 30, 2024 | 528,267.00 |
| Jun 30, 2024 | 601,634.00 |
| Mar 31, 2024 | 531,938.00 |
| Sep 30, 2023 | 514,952.00 |
| Jun 30, 2023 | 529,056.00 |
| Mar 31, 2023 | 567,019.00 |
| Dec 31, 2022 | 583,966.00 |
| Sep 30, 2022 | 466,342.00 |
| Jun 30, 2022 | 528,329.00 |
| Mar 31, 2022 | 685,179.00 |
| Dec 31, 2021 | 435,526.00 |
| Sep 30, 2021 | 443,698.00 |
| Jun 30, 2021 | 421,724.00 |
| Mar 31, 2021 | 425,152.00 |
API Access
Immucell Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();